» Articles » PMID: 37855350

GDF15 Interference Regulates Proliferation, Inflammation, and Autophagy of Lipopolysaccharide-induced Mesangial Cells by Inhibiting PI3K/ AKT/mTOR Signaling

Overview
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Chronic glomerulonephritis (CGN) is a primary glomerular disease. As a circulating protein, growth and differentiation factor 15 (GDF15) participates in a variety of biological processes.

Objective: We aimed to investigate the role of GDF15 in CGN.

Methods: HBZY-1 cells were induced by lipopolysaccharide (LPS). Cell viability was detected using a cell counting kit-8 (CCK-8) assay, and a western blot was applied for the detection of GDF15 protein expression. After GDF15 silencing, cell proliferation was evaluated by CCK-8 assay and 5-ethynyl-2'-deoxyuridine (EDU) staining. Enzyme-linked immunosorbent assay (ELISA) kits were used to detect the levels of inflammatory cytokines. Autophagy was assessed by GFP-LC3B assay. Besides, the expression of NF-κB signaling-, autophagy- (LC3II/I, Beclin l and p62) and phosphoinositide 3-kinase (PI3K)/protein kinase B (AKT)/mechanistic target of rapamycin (mTOR) signaling-related proteins were measured by western blot. Afterwards, PI3K agonist 740Y-P was used to clarify whether GDF15 affected LPS-induced HBZY-1 cells via PI3K/AKT/mTOR signaling.

Results: LPS induction increased cell viability and elevated GDF15 expression in HBZY-1 cells. After GDF15 expression depletion, the increased proliferation of LPS-induced HBZY-1 cells was decreased. Additionally, GDF15 knockdown suppressed the release of inflammatory factors in LPS-induced HBZY-1 cells and activated autophagy. Moreover, the PI3K/AKT/ mTOR signal was evidenced to be activated by GDF15 deficiency. The further addition of 740Y-P reversed the impacts of GDF15 deficiency on the proliferation, inflammation, and autophagy of LPS-induced HBZY-1.

Conclusion: Collectively, GDF15 downregulation could protect against CGN via blocking PI3K/AKT/mTOR signaling.

Citing Articles

GDF-15 Suppresses Puromycin Aminonucleoside-Induced Podocyte Injury by Reducing Endoplasmic Reticulum Stress and Glomerular Inflammation.

von Rauchhaupt E, Klaus M, Ribeiro A, Honarpisheh M, Li C, Liu M Cells. 2024; 13(7.

PMID: 38607075 PMC: 11011265. DOI: 10.3390/cells13070637.

References
1.
Provenzano M, Coppolino G, Faga T, Garofalo C, Serra R, Andreucci M . Epidemiology of cardiovascular risk in chronic kidney disease patients: the real silent killer. Rev Cardiovasc Med. 2020; 20(4):209-220. DOI: 10.31083/j.rcm.2019.04.548. View

2.
Hill N, Fatoba S, Oke J, Hirst J, OCallaghan C, Lasserson D . Global Prevalence of Chronic Kidney Disease - A Systematic Review and Meta-Analysis. PLoS One. 2016; 11(7):e0158765. PMC: 4934905. DOI: 10.1371/journal.pone.0158765. View

3.
Zhang L, Long J, Jiang W, Shi Y, He X, Zhou Z . Trends in Chronic Kidney Disease in China. N Engl J Med. 2016; 375(9):905-6. DOI: 10.1056/NEJMc1602469. View

4.
Chen W, Chen H, Yang Y, Yang S, Yang C, Wu Y . An Investigation of the Prescription Patterns of Chinese Herbal Products for Chronic Glomerulonephritis Patients: A Hospital-Based Cross-Sectional Study. Evid Based Complement Alternat Med. 2018; 2018:5080764. PMC: 6276402. DOI: 10.1155/2018/5080764. View

5.
Luan H, Wang A, Hilliard B, Carvalho F, Rosen C, Ahasic A . GDF15 Is an Inflammation-Induced Central Mediator of Tissue Tolerance. Cell. 2019; 178(5):1231-1244.e11. PMC: 6863354. DOI: 10.1016/j.cell.2019.07.033. View